• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植术后早期嵌合现象反映丙型肝炎复发的临床进程。

Early Chimerism After Liver Transplantation Reflects the Clinical Course of Recurrent Hepatitis C.

作者信息

Utsumi Masashi, Takaki Akinobu, Umeda Yuzo, Koike Kazuko, Napier Stephanie C, Watanabe Nobukazu, Shinoura Susumu, Yoshida Ryuichi, Nobuoka Daisuke, Yasunaka Tetsuya, Oto Takahiro, Araki Motoo, Yamamoto Kazuhide, Fujiwara Toshiyoshi, Yagi Takahito

机构信息

Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.

Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.

出版信息

Ann Transplant. 2017 Mar 24;22:156-165. doi: 10.12659/aot.900494.

DOI:10.12659/aot.900494
PMID:28336908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12577519/
Abstract

BACKGROUND Human leukocyte antigen (HLA) mismatch is a characteristic feature of post-orthotopic liver transplantation (OLT) hepatitis C. To investigate the importance of donor HLA-restricted immune cells in post-OLT hepatitis C recurrence, we analyzed the frequency of donor chimerism and the clinical course of post-OLT hepatitis C. MATERIAL AND METHODS We analyzed peripheral blood chimerism in 11 HCV-reinfected patients with post-HLA mismatched OLT. Patients were divided into 2 groups: the OLT chronic hepatitis C (CHC) group (n=8), exhibiting active hepatitis C recurrence; and the OLT-persistently normal ALT (PNALT) group (n=3), without active hepatitis. Chimerism was analyzed by flow cytometry using donor-specific anti-HLA antibodies in peripheral blood mononuclear cells from 1-100 days after OLT. Kidney (n=7) and lung (n=7) transplant recipients were also analyzed for comparison. As immune cells from the donor liver might contribute to post-OLT chimerism, the characteristics of perfusates from donor livers (n=10) were analyzed and defined. RESULTS Donor-derived cells were frequently observed in liver and lung transplant recipients. The frequency of donor-derived cells from the B cell subset was significantly higher in peripheral blood from OLT-CHC group than in that of the OLT-PNALT group. B cells, however, were not the predominant subset in the perfusates, indicating that inflow of donor-derived cells alone did not cause the chimerism. CONCLUSIONS Chimerism of B cells is frequent in liver transplant patients with early recurrence of hepatitis C. We propose that monitoring of early chimerism could facilitate early detection of chronic hepatitis C recurrence, although we need more cases to investigate.

摘要

背景 人类白细胞抗原(HLA)不匹配是原位肝移植(OLT)后丙型肝炎的一个特征。为了研究供体HLA限制性免疫细胞在OLT后丙型肝炎复发中的重要性,我们分析了供体嵌合体的频率以及OLT后丙型肝炎的临床病程。材料与方法 我们分析了11例HLA不匹配的OLT后丙型肝炎病毒再感染患者的外周血嵌合体情况。患者分为两组:OLT慢性丙型肝炎(CHC)组(n = 8),表现为丙型肝炎复发活跃;OLT持续正常丙氨酸转氨酶(PNALT)组(n = 3),无丙型肝炎活动。在OLT后1至100天,使用供体特异性抗HLA抗体通过流式细胞术分析外周血单个核细胞中的嵌合体情况。还分析了肾移植受者(n = 7)和肺移植受者(n = 7)作为对照。由于来自供体肝脏的免疫细胞可能促成OLT后的嵌合体,因此分析并确定了10例供体肝脏灌洗液的特征。结果 在肝移植和肺移植受者中经常观察到供体来源的细胞。OLT-CHC组外周血中B细胞亚群的供体来源细胞频率明显高于OLT-PNALT组。然而,B细胞不是灌洗液中的主要亚群,这表明仅供体来源细胞的流入不会导致嵌合体。结论 丙型肝炎早期复发的肝移植患者中B细胞嵌合体很常见。我们建议监测早期嵌合体有助于早期发现慢性丙型肝炎复发,尽管我们需要更多病例进行研究。

相似文献

1
Early Chimerism After Liver Transplantation Reflects the Clinical Course of Recurrent Hepatitis C.肝移植术后早期嵌合现象反映丙型肝炎复发的临床进程。
Ann Transplant. 2017 Mar 24;22:156-165. doi: 10.12659/aot.900494.
2
Frequency of regulatory T-cell and hepatitis C viral antigen-specific immune response in recurrent hepatitis C after liver transplantation.肝移植后复发性丙型肝炎中调节性T细胞频率及丙型肝炎病毒抗原特异性免疫反应
Transpl Immunol. 2014 Jun;31(1):33-41. doi: 10.1016/j.trim.2014.05.006. Epub 2014 Jun 5.
3
Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.供体移植物脂肪变性对丙型肝炎病毒肝硬化肝移植术后总体结局及病毒复发的影响。
Liver Transpl. 2009 Jan;15(1):37-48. doi: 10.1002/lt.21566.
4
A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.丙型肝炎肝移植10年经验:500余例患者预后决定因素分析
Ann Surg. 2001 Sep;234(3):384-93; discussion 393-4. doi: 10.1097/00000658-200109000-00012.
5
Acute cellular rejection is associated with matrix metalloproteinase-2 genotype chimerism after orthotopic liver transplantation.原位肝移植后,急性细胞排斥反应与基质金属蛋白酶-2基因型嵌合现象有关。
Transplant Proc. 2013 Mar;45(2):558-63. doi: 10.1016/j.transproceed.2012.12.002.
6
Humoral immune response to hepatitis C after liver transplantation: assessment of a new recombinant immunoblot assay.肝移植后对丙型肝炎的体液免疫反应:一种新型重组免疫印迹法的评估
Am J Gastroenterol. 2000 Aug;95(8):2035-9. doi: 10.1111/j.1572-0241.2000.02264.x.
7
Hepatitis C genotypes in liver transplant recipients: distribution and 1-year follow-up.肝移植受者中的丙型肝炎基因型:分布及1年随访
Liver Transpl Surg. 1995 Nov;1(6):354-7. doi: 10.1002/lt.500010603.
8
Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.肝移植后纤维性胆汁淤积性肝炎的成功治疗。
Transplant Proc. 2011 Apr;43(3):905-8. doi: 10.1016/j.transproceed.2011.02.034.
9
Hepatitis C virus-specific T-cell response correlates with hepatitis activity and donor IL28B genotype early after liver transplantation.肝移植后早期,丙型肝炎病毒特异性T细胞反应与肝炎活动及供体IL28B基因型相关。
Acta Med Okayama. 2014;68(5):291-302. doi: 10.18926/AMO/52898.
10
Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation.肝移植后丙型肝炎病毒复发感染中自然杀伤细胞表型的前瞻性研究。
J Hepatol. 2009 Feb;50(2):314-22. doi: 10.1016/j.jhep.2008.10.018. Epub 2008 Nov 24.

本文引用的文献

1
Molecular Mechanisms to Control Post-Transplantation Hepatitis B Recurrence.控制移植后乙型肝炎复发的分子机制
Int J Mol Sci. 2015 Jul 30;16(8):17494-513. doi: 10.3390/ijms160817494.
2
Macrochimerism in Intestinal Transplantation: Association With Lower Rejection Rates and Multivisceral Transplants, Without GVHD.肠道移植中的微嵌合体:与较低的排斥率及多脏器移植相关,无移植物抗宿主病。
Am J Transplant. 2015 Oct;15(10):2691-703. doi: 10.1111/ajt.13325. Epub 2015 May 18.
3
Immune responses to HCV and other hepatitis viruses.对 HCV 和其他肝炎病毒的免疫反应。
Immunity. 2014 Jan 16;40(1):13-24. doi: 10.1016/j.immuni.2013.12.010.
4
Differential function of natural killer cells in the liver graft perfusate of Korean population.韩国人群肝移植灌注液中自然杀伤细胞的差异功能。
Transplant Proc. 2013 Oct;45(8):2886-91. doi: 10.1016/j.transproceed.2013.08.050.
5
Hematopoietic chimerism in liver transplantation patients and hematopoietic stem/progenitor cells in adult human liver.肝移植患者的造血嵌合体与成人肝脏中的造血干/祖细胞
Hepatology. 2012 Oct;56(4):1557-66. doi: 10.1002/hep.25820.
6
Viral interactions with B-cells contribute to increased regulatory T-cells during chronic HCV infection.病毒与 B 细胞的相互作用导致慢性 HCV 感染期间调节性 T 细胞增加。
Viral Immunol. 2011 Apr;24(2):119-29. doi: 10.1089/vim.2010.0077.
7
Migration of allosensitizing donor myeloid dendritic cells into recipients after liver transplantation.肝移植后同种异体致敏供者髓系树突状细胞向受者的迁移。
Liver Transpl. 2010 Jan;16(1):12-22. doi: 10.1002/lt.21961.
8
Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice.采用肝移植来源淋巴细胞进行过继性免疫治疗可在人类和人源化小鼠肝移植后诱导抗丙型肝炎病毒(HCV)活性。
J Clin Invest. 2009 Nov;119(11):3226-35. doi: 10.1172/JCI38374. Epub 2009 Oct 1.
9
Long-term follow-up of donor chimerism and tolerance after human liver transplantation.人类肝移植后供体嵌合现象与免疫耐受的长期随访
Liver Transpl. 2009 Jun;15(6):581-91. doi: 10.1002/lt.21736.
10
Chimerism and liver transplant tolerance.嵌合现象与肝移植耐受
J Hepatol. 2008 Sep;49(3):478-80. doi: 10.1016/j.jhep.2008.06.021. Epub 2008 Jul 11.